http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2695449-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b74695f4c6259a8598b722c1ef6eefa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccbdca7d6da263f9b8fd6d7a750ad5f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2017-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_524f42624c1b325b85a89e5142d109ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb14ea4c4851933ed54f95828e8fb7f6 |
| publicationDate | 2019-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2695449-A1 |
| titleOfInvention | Method for designing personalized therapy for an individual suffering from lung cancer and treated with cisplatin |
| abstract | Method for designing a personalized therapy for an individual suffering from lung cancer who has been treated with cisplatin. The present invention refers to an in vitro method for designing a personalized therapy for an individual suffering from lung cancer and who is going to be treated with cisplatin, which comprises determining the level of expression of the PGC-1alpha gene before and after treatment with cisplatin. where if the expression level of said gene is higher after than before the treatment, then the therapy comprises the administration of a second treatment based on the combination of cisplatin with a compound aimed at decreasing the OXPHOS function. |
| priorityDate | 2017-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.